Bennett I, Broom N J, Bruton G, Calvert S, Clarke B P, Coleman K, Edmondson R, Edwards P, Jones D, Osborne N F
Smith Kline Beecham Pharmaceuticals, Chemotherapeutic Research Centre, Surrey, UK.
J Antibiot (Tokyo). 1991 Mar;44(3):331-7. doi: 10.7164/antibiotics.44.331.
Sodium (5RS)-Z-6-(heterocyclylmethylene)penem-3-carboxylates (2) are a series of extremely potent inhibitors of bacterial beta-lactamases. A variety of 5-membered heteroaromatic derivatives have been prepared and structure-activity studies reveal a preferred substituent orientation. One of these derivatives, the 1-methyl-1,2,3-triazolyl compound (5m) is a more potent synergist of amoxycillin than clavulanic acid, sulbactam or tazobactam.
(5RS)-Z-6-(杂环基亚甲基)青霉烷-3-羧酸钠(2)是一系列极具效力的细菌β-内酰胺酶抑制剂。已制备了多种五元杂芳族衍生物,构效关系研究揭示了一种优选的取代基取向。这些衍生物之一,即1-甲基-1,2,3-三唑基化合物(5m),是比克拉维酸、舒巴坦或他唑巴坦更有效的阿莫西林增效剂。